Isatuximab monotherapy or combination therapy with dexamethasone in older adult patients with relapsed/refractory multiple myeloma: a single institution experience

被引：0
|
作者：
Iino, Masaki [1 ]
Mikawa, Takahiro [1 ]
Kido, Shinji [1 ]
Fujimori, Ken [1 ]
机构：
[1] Yamanashi Prefectural Cent Hosp, Yamanashi, Japan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-273
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [21] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
  • [22] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    Blood Cancer Journal, 2014, 4 : e182 - e182
  • [23] Healthcare utilization and costs among relapsed or refractory multiple myeloma patients on carfilzomib or pomalidomide as monotherapy or in combination with dexamethasone
    Hagiwara, May
    Panjabi, Sumeet
    Sharma, Arati
    Delea, Thomas E.
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (08) : 818 - 829
  • [24] Preliminary Results from a Phase Ib Study of Isatuximab in Combination with Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma
    Richardson, Paul G.
    Mikhael, Joseph
    Usmani, Saad Z.
    Raje, Noopur
    Bensinger, William
    Campana, Frank
    Gao, Lei
    Dubin, Franck
    Wack, Claudine
    Anderson, Kenneth C.
    BLOOD, 2016, 128 (22)
  • [25] Combination therapy with velcade, doxil, and dexamethasone (VDD) for patients with relapsed/refractory multiple myeloma (MM).
    Jakubowiak, AJ
    Brackett, L
    Kendall, T
    Friedman, J
    Kaminski, MS
    BLOOD, 2005, 106 (11) : 378B - 378B
  • [26] Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma
    Matsue, Kosei
    Iwasaki, Hiromi
    Chou, Takaaki
    Tobinai, Kensei
    Sunami, Kazutaka
    Ogawa, Yoshiaki
    Kurihara, Mari
    Midorikawa, Shuichi
    Zaki, Mohamed
    Doerr, Thomas
    Iida, Shinsuke
    CANCER SCIENCE, 2015, 106 (11): : 1561 - 1567
  • [27] Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study
    Lesokhin, Alexander
    LeBlanc, Richard
    Dimopoulos, Meletios A.
    Capra, Marcelo
    Carlo-Stella, Carmelo
    Karlin, Lionel
    Castilloux, Jean-Francois
    Forsberg, Peter
    Parmar, Gurdeep
    Tosikyan, Axel
    Pour, Ludek
    Ribrag, Vincent
    Ribolla, Rossella
    Abdallah, Al-Ola
    Le Roux, Nadia
    Dong, Liyan
    van de Velde, Helgi
    Mayrargue, Laurent
    Lepine, Lucie
    Mace, Sandrine
    Moreau, Philippe
    CANCER MEDICINE, 2023, 12 (09): : 10254 - 10266
  • [28] Isatuximab plus pomalidomide and dexamethasone in frail individuals with relapsed/refractory multiple myeloma in Japan
    Nami Tagami
    Michihiro Uchiyama
    Kenshi Suzuki
    Heigoroh Shirai
    Takeshi Seto
    Shinsuke Iida
    International Journal of Hematology, 2025, 121 (4) : 476 - 482
  • [29] The Combination of Isatuximab with Pomalidomide and Dexamethasone in Second Line Relapse and Refractory Multiple Myeloma
    Bobin, Arthur
    Soufyane, Ennebet
    Guidez, Stephanie
    Chacon, Aurelia
    Gardeney, Helene
    Basle, Caroline
    Dindinaud, Elodie
    Douma, Soukaina
    Roul, Christophe
    Corby, Anne
    Motard, Carine
    Olivier, Gaelle
    Denis, Guillaume
    Vinson, Camille
    Tomowiak, Cecile
    Gruchet, Cecile
    Moya, Niels
    Mocquot, Pauline
    Dessane, Berangere
    Boscagli, Annick
    Perrot, Aurore
    Leleu, Xavier
    BLOOD, 2024, 144 : 7041 - 7042
  • [30] Erratum: Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    Blood Cancer Journal, 2014, 4 : e202 - e202
12345